Vistin Pharma AS

Vistin Pharma AS is a Manufacturer/Innovator company operating in the pharmaceutical industry.

The Vistin Pharma group was established in June 2015, when Vistin Pharma AS acquired the B2B business (metformin and opioid APIs) and tablet production assets of Weifa AS. With more than 75 years of pharmaceutical industry experience, the Group has built significant capacity and expertise as an API and Solid Dosage Form provider to producers all over the world, and Vistin Pharma’s APIs are marketed in more than 50 countries.

Company type

Manufacturer/Innovator

Products and services

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)

Address

Vistin Pharma AS, Ostensjovelen 27 , P.O. Box 6733, Oslo, Norway, 609